About
Team
Pipeline
OPN-2853
OPN-7486
OPN-6602
OPN-9627
OPN-TEAD
OPN-FMRP
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
2022
Select PROGRAMS
All Programs
OPN-2853
(6)
OPN-51107
(17)
OPN-7486
(5)
Select Dates
All Dates
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
May 31, 2022
Publication
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine
AUTHORS
Kim, et al
Programs
OPN-51107
https://doi.org/10.1016/j.leukres.2022.106884